» Articles » PMID: 19241044

Transthyretin Mass Determination for Detection of Transthyretin Familial Amyloid

Overview
Specialty Molecular Biology
Date 2009 Feb 26
PMID 19241044
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The concentration range of plasma proteins exceeds the dynamic range of any single analytical method. It has been estimated that the concentration range of serum proteins exceeds ten orders of magnitude (1). Because of this, prior immunoselection of even abundant proteins facilitates the relative nonquantitative observations required to show structural abnormality in primary or in posttranslational structure. Determination of atypical proteins by mass measurement has been reported for genetic defects in glycosylation (2, 3) and for monitoring for transthyretin (TTR) defects (4). Here we describe a rapid method of purification and electrospray introduction of TTR into a mass spectrometer to detect mass changes due to amino acid substitutions. The method currently forms the basis for a clinical assay to ascertain TTR mutations resulting in amyloidosis.

Citing Articles

Systemic amyloidoses and proteomics: The state of the art.

Lavatelli F, di Fonzo A, Palladini G, Merlini G EuPA Open Proteom. 2018; 11:4-10.

PMID: 29900105 PMC: 5988550. DOI: 10.1016/j.euprot.2016.02.003.


Discordant results between biochemical and molecular transthyretin assays: lessons learned from a unique testing algorithm at the Mayo Clinic.

Reddi H, Thomas B, Willkomm K, Ferber M, Rumilla K, Raymond K J Genet. 2013; 92(3):599-604.

PMID: 24371183 DOI: 10.1007/s12041-013-0303-6.